US Stocks Mixed; Jobless Claims Drop More than Projected
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 100 points on Thursday. Following the market opening Thursday, the Dow ...
Source: businessinsider.com
Page 17 - Alimera Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alimera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alimera Sciences Today - Breaking & Trending Today
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with…
Source: biztoc.com
Alimera acquires US commercialization rights for Yutiq from EyePoint
Alimera Sciences acquired the U.S. commercialization rights for Yutiq, a treatment for chronic noninfectious uveitis affecting the posterior segment, from EyePoint Pharmaceuticals, according to a press release.
Source: healio.com
ALIM | Alimera Sciences Inc. Stock Overview (U.S.: Nasdaq)
Complete Alimera Sciences Inc. stock information by Barron's. View real-time ALIM stock price and news, along with industry-best analysis.
Source: barrons.com
Alimera Sciences Stock Jumps 23% After Acquiring U.S. Commercial Rights To YUTIQ
Shares of Alimera Sciences, Inc. (ALIM) are gaining over 23% on Thursday morning after the company announced its acquisition of additional commercialization rights for YUTIQ from EyePoint Pharmaceuticals Inc.
Source: rttnews.com